Showing results (121-130 of 195) with videos related to
Sort By:
Pageof 20
Nature Chemical Biology|September 8, 2009
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparumJing Yuan, Ronald L Johnson, Ruili Huang, et al.Journal of Biomolecular Screening|January 25, 2008
Quantitative high-throughput screening using a live-cell cAMP assay identifies small-molecule agonists of the TSH receptorSteve Titus, Susanne Neumann, Wei Zheng, et al.Toxicology and Applied Pharmacology|March 3, 2011
Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channelsMenghang Xia, Sampada A Shahane, Ruili Huang, et al.Drug Discovery Today|June 5, 2013
The Tox21 robotic platform for the assessment of environmental chemicals--from vision to realityMatias S Attene-Ramos, Nicole Miller, Ruili Huang, et al.ACS Medicinal Chemistry Letters|September 17, 2013
Identification of Potent and Selective Diphenylpropanamide RORγ InhibitorsJun R Huh, Erika E Englund, Hang Wang, et al.Molecular Endocrinology (Baltimore, Md.)|May 23, 2014
Research resource: modulators of glucocorticoid receptor activity identified by a new high-throughput screening assayJohn A Blackford, Kyle R Brimacombe, Edward J Dougherty, et al.Proceedings of the National Academy of Sciences of the United States of America|August 3, 2007
Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher diseaseWei Zheng, Janak Padia, Daniel J Urban, et al.Combinatorial Chemistry & High Throughput Screening|June 10, 2008
A high throughput fluorescence polarization assay for inhibitors of the GoLoco motif/G-alpha interactionAdam J Kimple, Adam Yasgar, Mark Hughes, et al.Frontiers in Pharmacology|May 29, 2019
The NCATS BioPlanet - An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical GenomicsRuili Huang, Ivan Grishagin, Yuhong Wang, et al.Nature Reviews. Drug Discovery|January 9, 2020
Publisher Correction: Therapies for rare diseases: therapeutic modalities, progress and challenges aheadErik Tambuyzer, Benjamin Vandendriessche, Christopher P Austin, et al.Pageof 20